-+ 0.00%
-+ 0.00%
-+ 0.00%

RHYTHM PHARMACEUTICALS ANNOUNCES HEALTH CANADA APPROVAL OF IMCIVREE® (SETMELANOTIDE) FOR WEIGHT MANAGEMENT IN ADULT AND PEDIATRIC PATIENTS 4 YEARS OF AGE AND OLDER WITH ACQUIRED HYPOTHALAMIC OBESITY

Reuters·09/22/2026 12:02:25

Veuillez vous connecter pour afficher les détails des actualités